A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Clinical trial NCT06981078 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06981078
- Sponsor
- Upstream Bio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2027-10-01
- Enrollment
- 666
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.